Scandinavian ChemoTech (Sweden) Market Value
| CMOTEC-B | SEK 1.74 0.04 2.35% |
| Symbol | Scandinavian |
Scandinavian ChemoTech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Scandinavian ChemoTech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Scandinavian ChemoTech.
| 10/31/2024 |
| 11/30/2024 |
If you would invest 0.00 in Scandinavian ChemoTech on October 31, 2024 and sell it all today you would earn a total of 0.00 from holding Scandinavian ChemoTech AB or generate 0.0% return on investment in Scandinavian ChemoTech over 30 days. Scandinavian ChemoTech is related to or competes with Hansa Biopharma, Saniona AB, and Oncopeptides. Scandinavian ChemoTech AB provides cancer care and pain management solutions More
Scandinavian ChemoTech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Scandinavian ChemoTech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Scandinavian ChemoTech AB upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 21.9 | |||
| Value At Risk | (7.21) | |||
| Potential Upside | 5.77 |
Scandinavian ChemoTech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Scandinavian ChemoTech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Scandinavian ChemoTech's standard deviation. In reality, there are many statistical measures that can use Scandinavian ChemoTech historical prices to predict the future Scandinavian ChemoTech's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.19) | |||
| Total Risk Alpha | (0.77) | |||
| Treynor Ratio | (0.18) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Scandinavian ChemoTech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Scandinavian ChemoTech Backtested Returns
Scandinavian ChemoTech owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0105, which indicates the firm had a -0.0105% return per unit of risk over the last 3 months. Scandinavian ChemoTech AB exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Scandinavian ChemoTech's Variance of 15.58, coefficient of variation of (3,850), and Risk Adjusted Performance of (0.01) to confirm the risk estimate we provide. The entity has a beta of 0.62, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Scandinavian ChemoTech's returns are expected to increase less than the market. However, during the bear market, the loss of holding Scandinavian ChemoTech is expected to be smaller as well. At this point, Scandinavian ChemoTech has a negative expected return of -0.0413%. Please make sure to validate Scandinavian ChemoTech's treynor ratio, and the relationship between the standard deviation and kurtosis , to decide if Scandinavian ChemoTech performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.29 |
Weak reverse predictability
Scandinavian ChemoTech AB has weak reverse predictability. Overlapping area represents the amount of predictability between Scandinavian ChemoTech time series from 31st of October 2024 to 15th of November 2024 and 15th of November 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Scandinavian ChemoTech price movement. The serial correlation of -0.29 indicates that nearly 29.0% of current Scandinavian ChemoTech price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.29 | |
| Spearman Rank Test | 0.04 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Scandinavian ChemoTech lagged returns against current returns
Autocorrelation, which is Scandinavian ChemoTech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Scandinavian ChemoTech's stock expected returns. We can calculate the autocorrelation of Scandinavian ChemoTech returns to help us make a trade decision. For example, suppose you find that Scandinavian ChemoTech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Scandinavian ChemoTech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Scandinavian ChemoTech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Scandinavian ChemoTech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Scandinavian ChemoTech stock over time.
Current vs Lagged Prices |
| Timeline |
Scandinavian ChemoTech Lagged Returns
When evaluating Scandinavian ChemoTech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Scandinavian ChemoTech stock have on its future price. Scandinavian ChemoTech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Scandinavian ChemoTech autocorrelation shows the relationship between Scandinavian ChemoTech stock current value and its past values and can show if there is a momentum factor associated with investing in Scandinavian ChemoTech AB.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Scandinavian Stock
Scandinavian ChemoTech financial ratios help investors to determine whether Scandinavian Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Scandinavian with respect to the benefits of owning Scandinavian ChemoTech security.